Functional status and health-related quality of life of elderly osteoarthritic patients treated with celecoxib

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 56, Issue 3, 2001, Pages M167-M175

  Lisse, J ^a   Espinoza, L ^a   Zhao, S Z ^a   Dedhiya, S D ^a   Osterhaus, J T ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; NAPROXEN; PLACEBO;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COXITIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL SYMPTOM; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; AGING; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HEALTH STATUS; HUMANS; MALE; NAPROXEN; OSTEOARTHRITIS; PROSPECTIVE STUDIES; PYRAZOLES; QUALITY OF LIFE; SULFONAMIDES;

EID: 0035119369     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/56.3.M167     Document Type: Article

References (50)

1. Adverse drug reactions: An overview of special considerations in the management of the elderly patient
2. Management of drug therapy in the elderly
3. Polypharmacy in the aged: Practical solutions
4. Risk for serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs
5. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs
6. Economics of osteoarthritis: A global perspective
7. Rehabilitation advances in the treatment of arthritis and musculoskeletal disease
8. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetominophen in the treatment of patients with osteoarthritis of the knee
9. Inhibition of platelet prostaglandin synthetase by oral aspirin
10. Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function
11. Conservative management of spinal osteoarthritis with glucosamine sulfate and chiropractic treatment
12. Osteoarthritis: How to diagnose and treat the painful joint
13. Nonsteroidal anti-inflammatory drugs and antihypertensires
14. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs
15. Renal complications of nonsteroidal anti-inflammatory drugs
16. Special considerations in the use of NSAIDs in the elderly
17. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
18. Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure
19. Effects of non-steroidal antiinflammatory drugs on fatty acid cyclooxygenase and prostaglandin hydroperoxidase activities
20. PGH synthase isoenzyme selectivity: The potential for safer nonsteroidal antiinflammatory drugs
21. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic
22. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
23. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain
24. A comparative study of signal versus aggregate methods of outcome measurement based on the WOMAC Osteoarthritis Index
25. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee
26. Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Volaren): Post validation reapplication of the WOMAC Osteoarthritis Index
27. What is the best way of assessing outcome after total knee replacement?
28. The effect of elective total hip replacement on health-related quality of life
29. Comparison of the Musculoskeletal Function Assessment questionnaire with the Short Form-36, the Western Ontario and McMaster Universities Osteoarthritis Index, and the Sickness Impact Profile health-status measures
30. Comparison of general internists, family physicians, and rheumatologists managing patients with symptoms of osteoarthritis of the knee
31. Correlation of measured range of hip motion following total hip arthroplasty and responses to a questionnaire
32. Quadriceps weakness and osteoarthritis of the knee
33. Comparison of the WOMAC (Western Ontario and McMaster Universities) osteoarthritis index and a self-report format of the self-administered Lequesne-Algofunctional index in patients with knee and hip osteoarthritis
34. Comparative measurement sensitivity of short and longer health status instruments
35. The responsiveness of generic and disease specific health status measures in 759 patients with rheumatoid arthritis (RA) [Poster 1393]
36. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality scaling assumptions, and reliability across diverse patient groups
37. Measuring health status in British patients with rheumatoid arthritis: Reliability, validity and responsiveness of the Short Form 36-item health survey (SF-36)
38. Use of the Short Form 36 (SF36) for health status measurement in rheumatoid arthritis
39. The SF-36 health survey (SF-36) as a generic outcome measure in clinical trials of patients with osteo- and rheumatoid arthritis: Relative validity of scales in relation to clinical measures of arthritis severity [Poster 1383]
40. A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts
41. Effectiveness of manual physical therapy and exercise in osteoarthritis of the knee
42. Predicting health care use among older osteoarthritis patients in an HMO
43. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis
44. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo